Finding high-quality dividend stocks doesn't have to be difficult or time consuming. By looking for stocks with underlying financial strength and reliable payouts, even beginning investors can unlock exceptional returns for years on end. Today, let's look at two dividend stocks with low risk and high dividend growth -- an ideal combination for even the most novel investor.
1. PepsiCo (NYSE: PEP )
Not only are Pepsi and its Frito-Lay business some of the most recognizable brands in the world, but the stock is also a dividend aristocrat. The S&P 500's Dividend Aristocrats list measures the performance of the top blue-chip companies that have consecutively raised their dividends for at least the part 25 years -- although in Pepsi's case, it just celebrated its 41st straight year of dividend increases. The company recently grew its dividend by 6% to an annual payout of $2.27 per share.
Pepsi enjoys a rich history of rewarding its shareholders, having paid a dividend every year since 1952. In fact, the stock has returned more than $58 billion to stockholders over the past 11 years alone through dividends and share buybacks.
Top 5 Undervalued Companies To Watch For 2015: Navios Maritime Holdings Inc. (NM)
Navios Maritime Holdings Inc. operates as a seaborne shipping and logistics company. It focuses on the transportation and transshipment of dry bulk commodities, including iron ore, coal, fertilizers, and grains. The company controls a fleet of 31 owned vessels and 26 chartered-in vessels totaling 5.8 million dwt. Its owned fleet comprises 14 Ultra Handymax, 11 Capesize, 1 Handysize, and 3 Panamax vessels, as well as 2 Panamax vessels under construction; and chartered-in vessels consists of 8 Capesize, 11 Panamax, 1 Handysize, and 6 Ultra Handymax vessels under long-term time charters. The company also engages in port terminal, river barge, and coastal cabotage operations; and charters its vessels under medium to long-term charters to trading houses, producers, and government-owned entities. In addition, it engages in operating ports and transfer station terminals; and handles vessels, barges, and push boats, as well as operates upriver transport facilities in the Hidrovia region. Further, the company engages in the transportation and handling of liquid cargoes through the ownership, operation, and trading of tanker vessels. It has operations primarily in North America, Europe, Asia, and South America. The company is headquartered in Piraeus, Greece.
Advisors' Opinion:- [By Nickey Friedman]
Navios Maritime Holdings (NYSE: NM ) has two operating segments: shipping and logistics. Analysts have already begun to raise their profit estimates for 2014, currently at $0.11 EPS up from $0.01 a week ago. Expect that number to continue to rise dramatically. Navios pays a $0.06 per share quarterly dividend and trades around 40% below its book value. It used to trade as high as $17 back in 2007.
5 Best High Dividend Stocks To Invest In Right Now: Hudson City Bancorp Inc.(HCBK)
Hudson City Bancorp, Inc. operates as the bank holding company for Hudson City Savings Bank that provides a range of retail banking services. It offers a range of deposit accounts, including passbook and statement savings accounts, interest-bearing transaction accounts, checking accounts, money market accounts, and time deposits, as well as IRA accounts and qualified retirement plans. The company?s loan portfolio primarily comprises one-to four-family first mortgage loans for residential properties; multi-family and commercial mortgage loans; construction loans; and consumer loans, such as fixed-rate second mortgage loans and home equity credit line loans, as well as collateralized passbook loans, overdraft protection loans, automobile loans, and secured and unsecured commercial lines of credit. As of December 31, 2009, it operated 95 branches located in 17 counties throughout the State of New Jersey; 10 branch offices in Westchester County, 9 branch offices in Suffolk Cou nty, 1 branch office each in Putnam and Rockland Counties, and 6 branch offices in Richmond County; and 9 branch offices in Fairfield County, Connecticut. The company was founded in 1868 and is based in Paramus, New Jersey.
Advisors' Opinion:- [By Lauren Pollock]
M&T Bank Corp.(MTB) and Hudson City Bancorp Inc.(HCBK) said they expect additional delays in completing their merger deal, and any action isn’t expected to occur until the latter half of 2014. “While all parties are disappointed that the transaction is delayed further, we are gratified that M&T continues to see the value in the Hudson City franchise,” said Hudson City CEO Ronald E. Hermance Jr.
- [By Geoff Gannon]
For example, a bank might explain why they choose to focus on a certain area ��as Hudson City (HCBK) does here:
��hrough our branch offices, we have operations in 10 of the top 50 counties in the United States ranked by median household income. Operating in high median household income counties fits well with our jumbo mortgage loan and consumer deposit business model��he northern New Jersey market represents the greatest concentration of population, deposits and income in New Jersey. The combination of these counties represents more than half of the entire New Jersey population and more than half of New Jersey households. The northern New Jersey market also represents the greatest concentration of Hudson City Savings retail operations ��both lending and deposit gathering ��and based on its high level of economic activity, we believe that the northern New Jersey market provides significant opportunities for future growth.��/p>
- [By Dan Caplinger]
Beyond the Dow, Hudson City Bancorp (NASDAQ: HCBK ) has dropped more than 5% after the bank and its proposed acquirer, M&T Bank (NYSE: MTB ) , said there would be a delay in completing their merger. M&T, which has slipped almost 4%, cited regulatory concerns from the Federal Reserve over its bank secrecy and anti-money-laundering programs. Despite the two banks' plan to extend their agreement until the end of January 2014, they aren't sure the merger will be complete even by then. Shareholders will still vote on the deal later this month, but the delay has to be disconcerting for investors on both sides.
- [By Eric Volkman]
M&T Bank (NYSE: MTB ) will take a little longer to absorb fellow lender Hudson City Bancorp (NASDAQ: HCBK ) . The companies said in a joint press release that they believe more time will be needed to address regulatory issues in order to effect the planned acquisition, first announced in Aug. 2012.
5 Best High Dividend Stocks To Invest In Right Now: PrimeEnergy Corporation(PNRG)
PrimeEnergy Corporation, through its subsidiaries, engages in the acquisition, exploration, development, and production of crude oil and natural gas in the United States. Its principal properties are located in Texas, Oklahoma, West Virginia, the Gulf of Mexico, New Mexico, Colorado, and Louisiana. The company operates 1,600 oil and gas wells, as well as owns non-operating interests in approximately 800 additional wells. It also provides well-servicing support operations, site-preparation, and construction services for oil and gas drilling and reworking operations, as well as contract services for third parties. In addition, the company involves in the acquisition of producing oil and gas properties through joint ventures with industry partners. As of December 31, 2010, it had proved reserves of 101 billion cubic feet of gas equivalent. The company was founded in 1973 and is based in Stamford, Connecticut.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Energy shares declined by just 0.08 percent in Monday's trading. However, top gainers in the sector included PrimeEnergy (NASDAQ: PNRG) and Dresser-Rand Group (NYSE: DRC). In trading on Monday, financial shares were relative laggards, down on the day by about 1.07 percent.
5 Best High Dividend Stocks To Invest In Right Now: Trovagene Inc (TROV)
TrovaGene, Inc. (TrovaGene), incorporated on April 26, 2002, is a development-stage molecular diagnostic company that focuses on the development and marketing of urine-based nucleic acid tests for patient/disease screening and monitoring. The Company's novel tests predominantly use transrenal DNA (Tr-DNA) and transrenal RNA (Tr-RNA). The Company's technology is used to all transrenal nucleic acids (Tr-NA). The Company�� urine-based test addresses market needs, such as women�� healthcare-fetal medicine-down syndrome, infectious diseases, cancer testing, transplantation, drug development and monitoring of therapeutic outcomes, ultra-sensitive analytical and detection system, technologies for the collection, shipment and storage of urine specimens, and transrenal nucleic acid extraction, and instrumentation/system platform.
On January 18, 2011, the Company entered into an asset purchase agreement pursuant to which the Company acquired a hybridoma able to produce a monoclonal antibody targeting the NPM1 biomarker. On February 8, 2011, the Company entered into a sublicense agreement with MLL Munchner Leukamielabor (MLL). In July, 2011, the Company entered into a sublicense agreement with Fairview Health Services (Fairview) for NPM1 patent rights.
In October 2011, the Company entered into a license agreement pursuant to which the Company licensed the patent rights to a specific gene mutation with respect to chronic lymphoblastic leukemia. On December 12, 2011, the Company entered into a license agreement pursuant to which the Company licensed the patent rights to hairy cell leukemia biomarkers. On February 1, 2012, the Company acquired the clinical laboratory improvement amendments (CLIA) laboratory assets of MultiGEN Diagnostics, Inc. (MultiGEN).
Advisors' Opinion:- [By Daniel Lauchheimer]
In the past few weeks, I wrote two articles about TrovaGene (TROV) -- one detailing the history of the DNA market generally and the molecular diagnostics -- and TROV's place therein -- market specifically, and the second detailing the company's internal valuation. In this article, I will value TROV on an external, relative basis. Specifically, I will compare TROV to another molecular diagnostics company, Exact Sciences (EXAS), and try to show that while the market seems to have given EXAS a fair shake, it has not done the same for TROV. I will prove this argument by looking at both companies' addressable markets, and their respective progress at bringing the products to market. However, before we take this deep dive into both companies, I will take a moment to review each of the companies' products, so we have a strong background before turning to the deeper analysis.
No comments:
Post a Comment